当前位置:首页 - 行情中心 - 欧康医药(833230) - 财务分析

欧康医药

(833230)

  

流通市值:2.33亿  总市值:9.30亿
流通股本:1890.79万   总股本:7563.14万

欧康医药(833230)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.09亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益40351.27万元,未分配利润10329.83万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产43772.56万元,负债3421.30万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入68,240,881.12242,810,197.99169,781,662.69112,225,810.15
营业总成本59,113,846.37228,406,123.63159,181,541.57103,137,248.31
营业利润10,319,424.7616,785,795.812,782,797.1310,500,803.71
利润总额10,320,989.7616,757,721.812,779,248.6310,501,047.21
净利润8,561,888.4716,479,709.112,660,076.6210,245,890.81
其他综合收益--23,834.47--
综合收益总额8,561,888.4716,455,874.6312,660,076.6210,245,890.81
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计252,728,292.63294,402,629.11284,921,611.04320,567,537.36
非流动资产合计184,997,343.03158,690,500.54135,105,663.88105,685,365.37
资产总计437,725,635.66453,093,129.65420,027,274.92426,252,902.73
流动负债合计28,750,898.555,844,213.6728,877,363.2437,894,557.11
非流动负债合计5,462,061.793,874,085.132,734,579.492,808,984.23
负债合计34,212,960.2959,718,298.831,611,942.7340,703,541.34
归属于母公司股东权益合计402,724,951.69393,209,412.92388,054,547.19385,549,361.39
股东权益合计403,512,675.37393,374,830.85388,415,332.19385,549,361.39
负债和股东权益合计437,725,635.66453,093,129.65420,027,274.92426,252,902.73
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计71,388,750.19274,349,624.16207,808,761.8157,890,673.48
经营活动现金流出小计82,109,924.67238,215,584.96190,577,889.4125,742,194.12
经营活动产生的现金流量净额-10,721,174.4836,134,039.217,230,872.432,148,479.36
投资活动现金流入小计115,627,354.17247,045,538.06200,206,644.85133,110,975.68
投资活动现金流出小计123,081,056.48403,340,238.41240,004,910.55221,472,063.39
投资活动产生的现金流量净额-7,453,702.31-156,294,700.35-39,798,265.7-88,361,087.71
筹资活动现金流入小计710,59047,803,92535,360,78525,000,000
筹资活动现金流出小计10,288,734.6668,874,548.5758,618,638.7843,493,423.5
筹资活动产生的现金流量净额-9,578,144.66-21,070,623.57-23,257,853.78-18,493,423.5
汇率变动对现金及现金等价物的影响183,136.6258,880.32524,459.53598,580.73
现金及现金等价物净增加额-27,569,884.85-140,972,404.4-45,300,787.55-74,107,451.12
期末现金及现金等价物余额24,000,446.4451,521,096.61147,192,713.47118,386,049.9
TOP↑